One key takeaway from the Patent Brokered Market Report 2023 is that buyers held the upper hand in 2023, which is expected to continue in 2024. Price drops, particularly when
The pharmaceutical industry is known for its high-stakes drug patent infringement cases. Recently, several industry leaders, such as AbbVie, Bayer, and Cipla, have been involved in high-stakes litigation cases, garnering
Acquiring highly valuable patents presents a significant opportunity to strengthen your patent portfolio and secure a competitive edge. However, what if, after acquiring the supposedly “gem patents,” you realize they
Securing a ruling in your favor in an infringement case is a win, but translating that into a fair financial recovery is the real challenge. This scenario is all too
Technical standards, evolving technologies, and scattered patent declarations complicate the process of determining standard essential patents (SEPs). This is further complicated by the need for manual searches across various databases,
Online resources such as product manuals and company websites are a good starting point for patent infringement analysis. However, these sources can often be inconclusive, making it difficult to determine
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have emerged as a transformative
While early identification of Wi-Fi 7 SEPs is the long-term vision, immediate dominance in the wireless domain comes from identifying the sellers of Wi-fi 6 patents with enforceable portfolios. Wi-Fi
Major players like ZTE, Xiaomi, Zyxel, Sagemcom, Maxlinear, TP-Link, Buffalo, Gemtek, and a few others have already begun marketing their Wi-Fi 7 routers, following the certifications received from the Wi-Fi
Like every other industry, Artificial Intelligence (AI) has also transformed intellectual property (IP). With reduced human effort, patent experts can refine how they read, analyze, and leverage IP. Unsurprisingly, multiple
Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the brink
IP Licensing is no longer a unique practice in dynamic technology domains. However, the key to success lies in finding the smartest and most creative strategy for analyzing infringement, which
Ironburg Inventions, known for its SCUF controllers, claimed that Valve’s Steam Controller infringed on its patents. Specifically, the patents in question were related to the back paddle design of controllers,
Identifying Standard Essential Patents (SEPs) is a resource-intensive task, especially when dealing with a large patent portfolio. In this process, manual analysis is the preferred method, but examining patents that
The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these oppositions is crucial
While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has been introduced